Publications

Kaddoura S, Varnava A, Oldershaw P. Assessment of right ventricular function in clinical practice. Primary Cardiology 1993; 20, (4), 19-23

Montgomery H, Clarkson P, Dollery C, Prasad K, Losi M-A, Hemingway H, Statters D, Jubb M, Varnava A, Moult J, World M, Deanfield J, Talmud P, McEwan J, Humphries S, McKenna W. Association of Angiotensin-Converting Enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96 (3):741-7

Varnava A. Coronary artery remodelling. Heart 1998; 79: 109-110

Varnava A, Kelly P, Davies S, Rickards A, Sigwart U. Multiple intracoronary stenting in native coronary arteries and saphenous vein grafts: a single center experience. J Interv Cardiol 1999;12(3):85-90

Elliott P, Sharma S, Varnava A, Poloniecki J, Rowlands E, McKenna WJ. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 1999;33(6):1596-601

Varnava A, Baboonian C, Davison F, de Cruz L, Elliott PM, Davies MJ, McKenna WJ.
A new mutation of the cardiac troponin T gene causes familial hypertrophic cardiomyopathy without hypertrophy. Heart 1999;82(5):621-4

Elliott P, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon N, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high-risk patients. J Am Coll Cardiol 2000;36(7):2212-8

Varnava A, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: the inter-relationship of disarray, fibrosis and small vessel disease. Heart 2000; 84(5):476-482

D’Cruz LG, Baboonian C, Phillimore HE, Taylor R, Elliott PM, Varnava A, Davison F, McKenna WJ, Carter ND. Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet. 2000;37(9):18

Varnava A, Davies MJ. The relation between coronary artery stenosis, plaque size and arterial remodelling. Heart 2001;86:207-11

Varnava A, Elliott PM, Sharma S, Davies MJ, McKenna WJ. Disarray as a marker of risk in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2001;88(3):275-279

Varnava A, Davison F, Coccolo F, Elliott PM, Baboonian C, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 2001;104(12):1380-1384

Varnava A, Sedgwick J, Timmis A. Variations in the length of hospital stay following acute myocardial infarction. Heart 2002; 87(3): 216-219

Varnava A, Mills PG, Davies MJ. Coronary artery remodelling and plaque vulnerability. Circulation 2002;105(8):939-43

Varnava A. Isolated left ventricular non-compaction: a distinct cardiomyopathy? Heart 2001; 86(6):599

Varnava A. The impact of gender on left ventricular remodelling in hypertrophic cardiomyopathy. International Journal of cardiology 2003; 88:16-7

Thamen R, Varnava A, Hamid MS, Firoozi S, Sachdev B, Condon M, Murphy R, Elliott PM, McKenna WJ. Pregnancy related complications in women with Hypertrophic cardiomyopathy. Heart 2003; 89:752-6

Adlan A, Prasad S, Varnava A. Sarcoidosis presenting as dilated cardiomyopathy. Heart 2011; 97: 1896

Keene D, Varnava A, Wallis W Pro-coagulable states leads to a sticky situation: coronary saddle embolism in a patient with known hypertrophic cardiomyopathy and atrial fibrillation. BMJ Case Reports 2012; doi:10.1136

Abstracts

Varnava A, Stevens M, Simonds A. Respiratory failure in spina bifida; aetiology and prognostic features. Am Rev Resp Dis 1992: 145; (4); 863A

Potter N, Varnava A, Simonds A. Sleep disordered breathing in spina bifida. Presented to British Sleep Society 1992

Varnava A, Joy M, Doherty J, Marber M, MacRae C. A 15-year district general hospital experience of the need for tertiary referral. Br Heart J 1994; 71, (5), 298A

Elliott P, Polonieki J, Sharma S, Varnava A, McKenna W. Relation of left ventricular hypertrophy to survival in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998; 31, (2). Suppl A; 26A

Elliott P, Sharma S, Prasad K, Varnava A, McKenna W. Outcome of patients with hypertrophic cardiomyopathy that survive cardiac arrest. J Am Coll Cardiol 1998;31, (2). Suppl A; 245A

Sharma S, Elliott P, Whyte G, Prasad K, Varnava A, McKenna W. Metabolic exercise testing in hypertrophic cardiomyopathy: relation of submaximal parameters to clinical features. J Am Coll Cardiol 1998;31 (2). Suppl A; 484A

Sharma S, Elliott PM, Whyte G, Prasad K, Varnava A, McKenna WJ. Cardiac dimensions in junior elite athletes. Heart 1998;79 Suppl. 1 A137

Varnava A, Elliott P, McKenna WJ, Davies M. Correlates of myocardial fibrosis in hypertrophic cardiomyopathy. Eur Heart J. 1998; 19:Suppl. A3624

Sharma S, Elliott PM, Varnava A, Mahon N, Norman M, McKenna WJ. Cardiopulmonary exercise is a useful method for differentiating physiological hypertrophy of the athlete’s heart from hypertrophic cardiomyopathy with mild hypertrophy. J Am Coll Cardiol 1999; 33 (2): Suppl A. 510A

Varnava A, Davies MJ. Relation between arterial dilatation (coronary artery remodelling) and stenosis in human coronary artery disease. J Am Coll Cardiol 1999; 33 (2): Suppl A. 509A

Varnava A, Elliott PM, Sharma S, McKenna WJ, Davies MJ. The influence of age and gender on the histopathology of patients with hypertrophic cardiomyopathy J Am Coll Cardiol 1999; 33 (2): Suppl A. 509A

Varnava A, Davison F, Coccolo F, Elliott PM, de Cruz L, Baboonian C, Davies MJ, McKenna WJ. A new mutation of the cardiac trponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. J Am Coll Cardiol 1999; 33 (2): Suppl A.495A

Varnava A, Elliott PM, Sharma S, Davies MJ, McKenna WJ. Clinical correlates of myocyte disarray in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33 (2): Suppl A.489A

Varnava A, Davison F, Elliott PM, Davies MJ, McKenna WJ. A mutation of the cardiac troponin T gene causes hypertrophic cardiomyopathy without hypertrophy. Heart 1999; 81: Suppl 1. A10

Varnava A, Elliott PM, Sharma S, Davies MJ, McKenna WJ Disarray as a marker of risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 1999; 20: Suppl S. A3377

Varnava A, Coccolo F, Davison F, Elliott PM, Davies MJ, McKenna WJ A mutation of the cardiac troponin T gene causes familial hypertrophic cardiomyopathy with normal LV mass. Eur Heart J. 1999; 20: Suppl S. A229

Sharma S, Elliott PM, Varnava AMD, Virdee MS, McKenna WJ. Chronotropic incompetence is an important determinant of functional limitation in hypertrophic cardiomyopathy. Eur Heart J. 1999; 20: Suppl S. A3382

Sharma S, Elliott PM, Varnava AMD, Virdee MS, McKenna WJ. Utility of metabolic exercise testing in the differentiation of physiological hypertrophy of the athlete’s heart from hypertrophic cardiomypathy. Eur Heart J. 1999; 20: Suppl S. A3388

Varnava A, Coccolo F, Davison F, Elliott PM, Davies MJ, McKenna WJ Disarray is greater in hearts with a troponin T mutation than in myosin heavy chain gene mutations. Circulation 1999; 100 (18): I618

Varnava A, Elliott PM, Mahon N, McKenna WJ Davies MJ, Hypertrophic cardiomyopathy and premature death in the young: the histological characteristics of patients aged 21 years and under . J Am Coll Cardiol 2000; 35 (2): Suppl A.191A

Varnava A, D’Cruz L, Coccolo F, Davison F, Elliott PM, Baboonian C, McKenna WJ Davies MJ, A de novo mutation of the troponin T gene in a patient with hypertrophic cardiomyopathy J Am Coll Cardiol 2000; 35 (2): Suppl A.201A

Varnava A, Mills PG, Davies MJ. The relation between coronary artery remodelling and plaque vulnerability. . J Am Coll Cardiol 2001; 37 (2): Suppl A.257A

Varnava A, Sedgwick J, Timmis A. Variations in the length of hospital stay following acute myocardial infarction. Heart 2001; 85 (1):A199

Ismail T, Jabbour A, Das B, Cowling T, Mistry N, Gulati A, Wage R, Clark S, Shakespeare C, Varnava A, Pennell D, Prasad S. Clinical and CMR predictors of outcome in HCM: role of late gad enhancement AHA 2011